HSTC
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.00 | $154,240 | -$223,990 |
| 2025 Q4 | -0.00 | $275,456 | -$371,240 |
| 2025 Q3 | -0.00 | $132,189 | -$858,240 |
| 2025 Q2 | -0.00 | $0 | -$83,170 |
| 2025 Q1 | -0.00 | $0 | $219,970 |
| 2024 Q4 | -0.00 | $0 | -$94,060 |
| 2024 Q3 | -0.00 | $0 | -$18,552 |
| 2024 Q2 | -0.00 | $0 | $18,520 |